Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Jubilant Pharmova has informed that the Company is organising a Conference Call on February 4, 2022 after submission of the financial results for the quarter ended December 31, 2021 to the Stock Exchanges. Details of the Conference Call are attached.
The above information is a part of company’s filings submitted to BSE.